⌘K

Login Start Free

Home/Filings/4/A/0001127602-16-040253

4/A//SEC Filing

ARIAD PHARMACEUTICALS INC 4/A

Accession 0001127602-16-040253

CIK 0000884731operating

View on SEC.gov Company Profile

Filed

Feb 8, 7:00 PM ET

Accepted

Feb 9, 5:31 PM ET

Size

7.4 KB

Accession

0001127602-16-040253

Insider Transaction Report

Form 4/AAmended

Period: 2016-02-01

ARIAD PHARMACEUTICALS INCARIA

Director

Transactions

Award
Stock Option (Right to Buy)
2016-02-01$4.91/sh+25,000$122,750→ 25,000 total
Exp: 2026-02-01→ Common Stock (25,000 underlying)
Award
Common Stock
2016-02-01+12,500→ 552,205 total

Holdings

Common Stock
(indirect: By Spouse)
6,696

Footnotes (1)

[F1]The stock options vest as to one-fourth of the options on each of March 31, 2016, June 30, 2016, September 30, 2016, and December 31, 2016.

Documents

1 file

4
form4a.xml
PRIMARY DOCUMENT

Issuer

ARIAD PHARMACEUTICALS INC

CIK 0000884731

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0000884731

Filing Metadata

Form type: 4/A
Filed: Feb 8, 7:00 PM ET
Accepted: Feb 9, 5:31 PM ET
Size: 7.4 KB

View on SEC.gov